Ampk Activation Restores the Stimulation of Glucose Uptake in an in Vitro Model of Insulin-resistant Cardiomyocytes Via the Activation of Protein Kinase B.
From: Division of Cardiology, School of Medicine, Université Catholique de Louvain, Brussels, Belgium. bertrand@card.ucl.ac.be
American journal of physiology. Heart and circulatory physiology
- Publish Date: Jul 2006
- ISSN: 0363-6135
- Volume: 291
- Issue: 1
- Pages: H239-50
- Medium: Print
- Language: English
- Citation (JAMA): Bertrand Luc, Ginion Audrey, Beauloye Christophe, et al. Ampk Activation Restores the Stimulation of Glucose Uptake in an in Vitro Model of Insulin-resistant Cardiomyocytes Via the Activation of Protein Kinase B.. Am. J. Physiol. Heart Circ. Physiol. Jul 2006;291:H239-50
Abstract
Diabetic hearts are known to be more susceptible to ischemic disease. Biguanides, like metformin, are known antidiabetic drugs that lower blood glucose concentrations by decreasing hepatic glucose production and increasing glucose disposal in muscle. Part of these metabolic effects is thought to be mediated by the activation of AMP-activated protein kinase (AMPK). In this work, we studied the relationship between AMPK activation and glucose uptake stimulation by biguanides and oligomycin, another AMPK activator, in both insulin-sensitive and insulin-resistant cardiomyocytes. In insulin-sensitive cardiomyocytes, insulin, biguanides and oligomycin were able to stimulate glucose uptake with the same efficiency. Stimulation of glucose uptake by insulin or biguanides was correlated to protein kinase B (PKB) or AMPK activation, respectively, and were additive. In insulin-resistant cardiomyocytes, where insulin stimulation of glucose uptake was greatly reduced, biguanides or oligomycin, in the absence of insulin, induced a higher stimulation of glucose uptake than that obtained in insulin-sensitive cells. This stimulation was correlated with the activation of both AMPK and PKB and was sensitive to the phosphatidylinositol-3-kinase/PKB pathway inhibitors. Finally, an adenoviral-mediated expression of a constitutively active form of AMPK increased both PKB phosphorylation and glucose uptake in insulin-resistant cardiomyocytes. We concluded that AMPK activators, like biguanides and oligomycin, are able to restore glucose uptake stimulation, in the absence of insulin, in insulin-resistant cardiomyocytes via the additive activation of AMPK and PKB. Our results suggest that AMPK activation could restore normal glucose metabolism in diabetic hearts and could be a potential therapeutic approach to treat insulin resistance.
Mesh Headings (Keywords): Animals, Biguanides, Cells, Cultured, Dose-Response Relationship, Drug, Drug Combinations, Enzyme Activation, Glucose, Insulin, Insulin Resistance, Male, Multienzyme Complexes, Myocytes, Cardiac, Oligomycins, Protein-Serine-Threonine Kinases, Proto-Oncogene Proteins c-akt, Rats, Rats, Wistar
Check for Full Text / PubMed Unique Identifier (PMID): 16489105
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.